Greenlight Capital Re, Ltd. is a specialty property and casualty reinsurance provider that could be an interesting play for investors. That is because, not only does the stock have decent short-term momentum, but it is seeing solid activity on the earnings estimate revision front as well.
These positive earnings estimate revisions suggest that analysts are becoming more optimistic on GLRE’s earnings for the coming quarter and year. In fact, consensus estimates have moved sharply higher for both of these time frames over the past four weeks, suggesting that Greenlight Capital Re could be a solid choice for investors.
Current Quarter Estimates for GLRE
In the past 30 days, 1 estimate has gone higher for Greenlight Capital Re while none have gone lower in the same time period. The trend has been pretty favorable too, with estimates increasing from 67 cents a share 30 days ago, to $1.16 per share today, a move of 73.1%.
Current Year Estimates for GLRE
Meanwhile, Greenlight Capital Re’s current year figures are also looking quite promising, with 1 estimate moving higher in the past month, while none have gone lower in the same time frame. The consensus estimate trend has also seen a boost for this time frame, increasing from 65 cents per share 30 days ago to $1.05 per share today, an increase of 61.5%.
The stock has also started to move higher lately, adding 8.2%over the past four weeks, suggesting that investors are starting to take note of this impressive story. So investors may definitely want to consider this Zacks Rank #2 (Buy) stock to profit in the near future. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
The Best Place to Start Your Stock Search
Today, you are invited to download the full, up-to-the-minute list of 220 Zacks Rank #1 "Strong Buy" stocks – absolutely free of charge. Since 1988, Zacks Rank #1 stocks have nearly tripled the market, with average gains of +26% per year. Plus, you can access the list of portfolio-killing Zacks Rank #5 "Strong Sells" and other private research. See these stocks free >>